Aptevo Therapeutics Inc.
APVOReported to SECin USCIK 0001671584Filings at SEC EDGAR
No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.
This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 24. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.
The most recent filings
Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.
| Filed by | Type | Value | Reported | Filed by | Value | Type | Shares | Reported |
|---|---|---|---|---|---|---|---|---|
| Harsanyi Zsolt— | Option exercise | nothing paid400 shares | Aug 10, 2026 | Harsanyi Zsolt | nothing paid | Option exercise | 400 | Aug 10, 2026 |
| Harsanyi Zsolt— | Option exercise | —400 shares | Aug 10, 2026 | Harsanyi Zsolt | — | Option exercise | 400 | Aug 10, 2026 |
| Lamothe Jeffrey G.President and CEO | Option exercise | nothing paid961 shares | Aug 10, 2026 | Lamothe Jeffrey G.President and CEO | nothing paid | Option exercise | 961 | Aug 10, 2026 |
| Lamothe Jeffrey G.President and CEO | Option exercise | —961 shares | Aug 10, 2026 | Lamothe Jeffrey G.President and CEO | — | Option exercise | 961 | Aug 10, 2026 |
| Taylor DaphneSVP, CFO | Option exercise | nothing paid638 shares | Aug 10, 2026 | Taylor DaphneSVP, CFO | nothing paid | Option exercise | 638 | Aug 10, 2026 |